Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis
Ospedale San Raffaele
40 participants
Apr 8, 2021
OBSERVATIONAL
Conditions
Summary
In this project the investigators aim to identify new biological markers by characterizing the response/inflammation associated with the development and progression of M. abscessus lung disease in patients suffering from cystic fibrosis with the aim of increasing current knowledge available on the development and progression of lung disease.
Eligibility
Inclusion Criteria4
- Patients with a certain diagnosis of cystic fibrosis and visited during normal clinical practice, in accordance with the standard operating procedures in force at the Centres.
- Both sexes
- Age \>18 years
- Obtaining informed consent for patients (based on the procedures established by the protocol).
Exclusion Criteria1
- Patients unable to understand the instructions and information provided and be able to adequately accept the study methods.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Evaluation of specific cell populations associated with development of M. abscessus lung disease; evaluation of circulating factors related to immunoresponses
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06413459